Status:
COMPLETED
Glycemic Index Evaluation of a Hypercaloric/High-protein Nutritional Supplement in Healthy Adults
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz
Collaborating Sponsors:
Fundacio Eurecat
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Diabetes mellitus (DM) is a chronic disease with a higher prevalence in the world population, especially in the elderly population.The main consequence of the alteration of DM is the increase in blood...
Detailed Description
Diabetes mellitus (DM) is a chronic disease with a higher prevalence in the world population, especially in the elderly population. It is considered one of the main health problems worldwide. Taking i...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- Men and women between 18 and 65 years
- Patients without chronic uncontrolled diseases
- Patients willing to consume the Oral Nutritional Supplement (ONS) to carry out the study
- Patients with adequate cultural level and understanding of the clinical study
- Patients who agree to voluntarily participate in the study and who give their informed consent in writing
- EXCLUSION CRITERIA
- Subjects with any serious chronic pathology.
- Subjects with metabolic or intestinal pathologies that interfere with the homeostatic mechanisms of glucose
- Subjects with neurological pathologies or eating disorders that interfere with acute tests.
- Subjects with allergies or intolerances to any of the ingredients in the formula
- Subjects with socio-family problems that prevent them from participating in the study
- Subjects with intense physical activity
- Pregnant or breastfeeding women
Exclusion
Key Trial Info
Start Date :
November 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2022
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05335863
Start Date
November 3 2021
End Date
February 9 2022
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Health Research IdiPAZ
Madrid, Spain, 28046